Gate2Brain technology seeks to increase the effectiveness and reduce the side effects of treatments for brain disease.
The company focuses its activity on the development of a new medicine for the treatment of metastatic cancer.
This is the largest private funding round closed for a start-up in Spain.
Is IRB Barcelona’s challenge to bring people and organisations together in support of research into metastasis.
Together we can beat metastasis.
We have made ourselves available to health authorities, putting our infrastructure, equipment and knowledge at the service of society.